• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment.系统性硬化症相关原发性心脏受累评估共识:世界硬皮病基金会/心力衰竭协会关于筛查、诊断及随访评估的指南
J Scleroderma Relat Disord. 2023 Oct;8(3):169-182. doi: 10.1177/23971983231163413. Epub 2023 Apr 3.
2
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition.原发性系统性硬化症心脏受累:一项系统文献综述以及基于数据驱动和共识的WSF/HFA初步定义
J Scleroderma Relat Disord. 2022 Feb;7(1):24-32. doi: 10.1177/23971983211053246. Epub 2021 Oct 26.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements.系统性硬化症中间质性肺疾病的识别与管理:基于证据的欧洲共识声明
Lancet Rheumatol. 2020 Feb;2(2):e71-e83. doi: 10.1016/S2665-9913(19)30144-4. Epub 2020 Jan 14.
5
Consensus best practice pathway of the UK Systemic Sclerosis Study group: management of cardiac disease in systemic sclerosis.英国系统性硬化症研究小组的共识最佳实践路径:系统性硬化症中心脏病的管理
Rheumatology (Oxford). 2017 Jun 1;56(6):912-921. doi: 10.1093/rheumatology/kew488.
6
Defining Skin Ulcers in Systemic Sclerosis: Systematic Literature Review and Proposed World Scleroderma Foundation (WSF) definition.系统性硬化症中皮肤溃疡的定义:系统文献综述及世界硬皮病基金会(WSF)提议的定义
J Scleroderma Relat Disord. 2017 May;2(2):115-120. doi: 10.5301/jsrd.5000236. Epub 2017 May 19.
7
Recommendations for the execution and reporting of skin ultrasound in systemic sclerosis: an international collaboration under the WSF skin ultrasound group.系统性硬化症皮肤超声操作和报告的建议:WSF 皮肤超声工作组的国际协作。
RMD Open. 2022 Jul;8(2). doi: 10.1136/rmdopen-2022-002371.
8
Setting the international standard for longitudinal follow-up of patients with systemic sclerosis: a Delphi-based expert consensus on core clinical features.为系统性硬化症患者的纵向随访设定国际标准:基于德尔菲法的核心临床特征专家共识。
RMD Open. 2019 Mar 4;5(1):e000826. doi: 10.1136/rmdopen-2018-000826. eCollection 2019.
9
[Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].[Birt-Hogg-Dubé综合征诊断与管理专家共识]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Sep 12;46(9):897-908. doi: 10.3760/cma.j.cn112147-20230705-00362.
10
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].[中国专家共识声明:囊性纤维化的诊断与治疗(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.

引用本文的文献

1
A multi-biomarker approach to risk stratification and detection of early cardiac disease in systemic sclerosis.一种用于系统性硬化症早期心脏病风险分层和检测的多生物标志物方法。
PLoS One. 2025 Jul 31;20(7):e0328734. doi: 10.1371/journal.pone.0328734. eCollection 2025.
2
Factors associated with pericardial effusion development and persistence in systemic sclerosis: a single-centre retrospective analysis.系统性硬化症中心包积液发生和持续存在的相关因素:一项单中心回顾性分析。
Rheumatol Int. 2025 Jul 14;45(8):169. doi: 10.1007/s00296-025-05925-0.
3
International expert agreement on World Scleroderma Foundation/Heart Failure Association consensus-based definition and guidance on screening, diagnosis, and follow-up assessment of systemic sclerosis-associated primary heart involvement.关于世界硬皮病基金会/心力衰竭协会基于共识的系统性硬化症相关原发性心脏受累的筛查、诊断和随访评估定义及指南的国际专家共识。
J Scleroderma Relat Disord. 2025 Mar 19:23971983251321691. doi: 10.1177/23971983251321691.
4
Evaluation of Systemic Sclerosis Primary Heart Involvement and Chronic Heart Failure in the European Scleroderma Trials and Research Cohort.欧洲硬皮病试验与研究队列中系统性硬化症原发性心脏受累及慢性心力衰竭的评估
J Am Heart Assoc. 2025 Mar 4;14(5):e036730. doi: 10.1161/JAHA.124.036730. Epub 2025 Feb 26.
5
Myocardial Disease in Systemic Sclerosis: Recent Updates and Clinical Implications.系统性硬化症中的心肌病:最新进展与临床意义
Curr Cardiol Rep. 2025 Jan 4;27(1):3. doi: 10.1007/s11886-024-02164-w.
6
Coronary artery calcification is prevalent in systemic sclerosis and is associated with adverse prognosis.冠状动脉钙化在系统性硬化症中很常见,且与不良预后相关。
J Scleroderma Relat Disord. 2024 Oct;9(3):192-202. doi: 10.1177/23971983241264090. Epub 2024 Aug 11.
7
Add-on rituximab for primary heart involvement associated with systemic sclerosis: A step forward in the tailored treatment of myocarditis?利妥昔单抗用于治疗系统性硬化症相关的原发性心脏受累:心肌炎个体化治疗向前迈进了一步?
Eur J Heart Fail. 2025 Mar;27(3):473-475. doi: 10.1002/ejhf.3467. Epub 2024 Sep 24.
8
Autoantibodies, cutaneous subset and immunosuppressants contribute to the cancer risk in systemic sclerosis.自身抗体、皮肤亚型和免疫抑制剂导致系统性硬化症的癌症风险增加。
RMD Open. 2024 Sep 20;10(3):e004492. doi: 10.1136/rmdopen-2024-004492.
9
The 2024 British Society for Rheumatology guideline for management of systemic sclerosis.2024 年英国风湿病学会系统性硬化症管理指南。
Rheumatology (Oxford). 2024 Nov 1;63(11):2956-2975. doi: 10.1093/rheumatology/keae394.
10
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases.风湿免疫性炎症性疾病中心血管受累的当前认识和管理。
Nat Rev Rheumatol. 2024 Oct;20(10):614-634. doi: 10.1038/s41584-024-01149-x. Epub 2024 Sep 2.

本文引用的文献

1
Cardiac magnetic resonance imaging before and after therapeutic interventions for systemic sclerosis-associated myocarditis.系统性硬化症相关性心肌炎治疗干预前后的心脏磁共振成像
Rheumatology (Oxford). 2023 Apr 3;62(4):1535-1542. doi: 10.1093/rheumatology/keac504.
2
Primary systemic sclerosis heart involvement: A systematic literature review and preliminary data-driven, consensus-based WSF/HFA definition.原发性系统性硬化症心脏受累:一项系统文献综述以及基于数据驱动和共识的WSF/HFA初步定义
J Scleroderma Relat Disord. 2022 Feb;7(1):24-32. doi: 10.1177/23971983211053246. Epub 2021 Oct 26.
3
NT-proBNP, hs-cTnT, and CRP predict the risk of cardiopulmonary outcomes in systemic sclerosis: Findings from the Canadian Scleroderma Research Group.N末端B型利钠肽原、高敏心肌肌钙蛋白T和C反应蛋白可预测系统性硬化症患者心肺不良结局的风险:加拿大硬皮病研究小组的研究结果
J Scleroderma Relat Disord. 2022 Feb;7(1):62-70. doi: 10.1177/23971983211040608. Epub 2021 Sep 3.
4
Update on assessment and management of primary cardiac involvement in systemic sclerosis.系统性硬化症中心脏原发性受累的评估与管理进展
J Scleroderma Relat Disord. 2018 Feb;3(1):53-65. doi: 10.1177/2397198317747441. Epub 2018 Apr 4.
5
Serum Organ-Specific Anti-Heart and Anti-Intercalated Disk Autoantibodies as New Autoimmune Markers of Cardiac Involvement in Systemic Sclerosis: Frequency, Clinical and Prognostic Correlates.血清器官特异性抗心脏和抗闰盘自身抗体作为系统性硬化症心脏受累的新型自身免疫标志物:频率、临床及预后相关性
Diagnostics (Basel). 2021 Nov 22;11(11):2165. doi: 10.3390/diagnostics11112165.
6
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure.2021年欧洲心脏病学会急性和慢性心力衰竭诊断与治疗指南。
Eur Heart J. 2021 Sep 21;42(36):3599-3726. doi: 10.1093/eurheartj/ehab368.
7
Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis.微血病变和心肌纤维化特征的亚临床系统性硬化症原发性心脏受累的预测因素。
Rheumatology (Oxford). 2021 Jun 18;60(6):2934-2945. doi: 10.1093/rheumatology/keaa742.
8
Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy.ESC 心力衰竭协会、美国心力衰竭学会和日本心力衰竭学会关于心内膜心肌活检的立场声明。
Eur J Heart Fail. 2021 Jun;23(6):854-871. doi: 10.1002/ejhf.2190. Epub 2021 May 19.
9
Interleukin-1 and Systemic Sclerosis: Getting to the Heart of Cardiac Involvement.白细胞介素-1 与系统性硬化症:直击心脏受累的核心。
Front Immunol. 2021 Mar 23;12:653950. doi: 10.3389/fimmu.2021.653950. eCollection 2021.
10
Cardiac involvement in systemic sclerosis: Getting to the heart of the matter.系统性硬化症中的心脏受累:直击问题核心。
Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101668. doi: 10.1016/j.berh.2021.101668. Epub 2021 Mar 15.

系统性硬化症相关原发性心脏受累评估共识:世界硬皮病基金会/心力衰竭协会关于筛查、诊断及随访评估的指南

Consensus on the assessment of systemic sclerosis-associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment.

作者信息

Bruni Cosimo, Buch Maya H, Djokovic Aleksandra, De Luca Giacomo, Dumitru Raluca B, Giollo Alessandro, Galetti Ilaria, Steelandt Alexia, Bratis Konstantinos, Suliman Yossra Atef, Milinkovic Ivan, Baritussio Anna, Hasan Ghadeer, Xintarakou Anastasia, Isomura Yohei, Markousis-Mavrogenis George, Mavrogeni Sophie, Gargani Luna, Caforio Alida Lp, Tschöpe Carsten, Ristic Arsen, Plein Sven, Behr Elijah, Allanore Yannick, Kuwana Masataka, Denton Christopher P, Furst Daniel E, Khanna Dinesh, Krieg Thomas, Marcolongo Renzo, Pepe Alessia, Distler Oliver, Sfikakis Petros, Seferovic Petar, Matucci-Cerinic Marco

机构信息

Division of Rheumatology, Department of Experimental and Clinical Medicine, Careggi University Hospital (AOUC), University of Florence, Florence, Italy.

Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

出版信息

J Scleroderma Relat Disord. 2023 Oct;8(3):169-182. doi: 10.1177/23971983231163413. Epub 2023 Apr 3.

DOI:10.1177/23971983231163413
PMID:37744047
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10515996/
Abstract

INTRODUCTION

Heart involvement is a common problem in systemic sclerosis. Recently, a definition of systemic sclerosis primary heart involvement had been proposed. Our aim was to establish consensus guidance on the screening, diagnosis and follow-up of systemic sclerosis primary heart involvement patients.

METHODS

A systematic literature review was performed to investigate the tests used to evaluate heart involvement in systemic sclerosis. The extracted data were categorized into relevant domains (conventional radiology, electrocardiography, echocardiography, cardiac magnetic resonance imaging, laboratory, and others) and presented to experts and one patient research partner, who discussed the data and added their opinion. This led to the formulation of overarching principles and guidance statements, then reviewed and voted on for agreement. Consensus was attained when the mean agreement was ⩾7/10 and of ⩾70% of voters.

RESULTS

Among 2650 publications, 168 met eligibility criteria; the data extracted were discussed over three meetings. Seven overarching principles and 10 guidance points were created, revised and voted on. The consensus highlighted the importance of patient counseling, differential diagnosis and multidisciplinary team management, as well as defining screening and diagnostic approaches. The initial core evaluation should integrate history, physical examination, rest electrocardiography, trans-thoracic echocardiography and standard serum cardiac biomarkers. Further investigations should be individually tailored and decided through a multidisciplinary management. The overall mean agreement was 9.1/10, with mean 93% of experts voting above 7/10.

CONCLUSION

This consensus-based guidance on screening, diagnosis and follow-up of systemic sclerosis primary heart involvement provides a foundation for standard of care and future feasibility studies that are ongoing to support its application in clinical practice.

摘要

引言

心脏受累是系统性硬化症中的常见问题。最近,有人提出了系统性硬化症原发性心脏受累的定义。我们的目的是就系统性硬化症原发性心脏受累患者的筛查、诊断和随访建立共识性指南。

方法

进行了一项系统的文献综述,以研究用于评估系统性硬化症心脏受累情况的检查。提取的数据被分类到相关领域(传统放射学、心电图、超声心动图、心脏磁共振成像、实验室检查及其他),并提交给专家和一名患者研究伙伴,他们对数据进行了讨论并发表了意见。这促成了总体原则和指导声明的制定,然后进行了审查并投票表决是否达成一致。当平均同意率⩾7/10且⩾70%的投票者同意时,即达成共识。

结果

在2650篇出版物中,168篇符合纳入标准;提取的数据在三次会议上进行了讨论。创建、修订并投票表决了七条总体原则和十条指导要点。共识强调了患者咨询、鉴别诊断和多学科团队管理的重要性,以及明确筛查和诊断方法。初始核心评估应综合病史、体格检查、静息心电图、经胸超声心动图和标准血清心脏生物标志物。进一步的检查应根据个体情况进行定制,并通过多学科管理来决定。总体平均同意率为9.1/10,平均93%的专家投票高于7/10。

结论

这份关于系统性硬化症原发性心脏受累筛查、诊断和随访的基于共识的指南为护理标准以及正在进行的支持其在临床实践中应用的未来可行性研究奠定了基础。